Department of Bioengineering and Therapeutic Sciences

June 14, 2024, marked the 15-year collaboration of a Chinese course improving medical product development and regulation.

The pioneering career of one of the School’s most influential faculty members was honored on his 87th birthday.

Bhushan Kharbikar, PhD, a postdoctoral fellow in the laboratories of Professors Qizhi Tang, PhD, and Tejal Desai, PhD, has been awarded a prestigious JDRF Advanced Postdoctoral Fellowship. JDRF is the leading global organization funding type 1 diabetes (T1D) research.

Executive Assistant

As an executive assistant in the Department of Bioengineering and Therapeutic Sciences, I support faculty member Rada Savic, PhD, and the Savic Integrative Pharmacology Research Laboratory. I manage schedules, prepare meeting materials, and coordinate executive meetings, communications, and events...

The Preclinical Design and Clinical Translation of TB Regimens (PReDicTR) Consortium has been awarded a $30.8M grant over five years to research the most effective treatment options for future clinical testing.

Post Award Analyst

As the Research and Finance Analyst, I currently support the BioE program.

Executive Business Admin

In my role as Executive Business Administrator, I provide administrative support to James Fraser, Department Chair of Bioengineering and Therapeutic Sciences focusing on the Department’s values, mission, and vision.

School researchers netted $36.7M from 65 grants, fueling efforts spanning drug discovery, bioengineering, pharmacokinetics, clinical pharmacy, and more.

Attend in person at Mission Bay or on Zoom at 3:30 p.m. Pacific on Tuesday, April 16. Reception to follow.

The first program of its kind in the United States, the MS in AICD3 will enable its graduates to gain a competitive edge for some of the most desirable jobs in the biopharmaceutical industry and in academia.